{"nct_id":"NCT06261957","title":"A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2024-05-31","start_date_type":"ACTUAL","primary_completion_date":"2025-09-05","primary_completion_date_type":"ESTIMATED","completion_date":"2025-09-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}